ArticleCureus2026
Cardiorenal Syndrome in a Kidney Transplant Recipient With High-Flow Arteriovenous Fistula and Mycotic Pneumonia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The arteriovenous fistula (AVF) is a preferred access for haemodialysis (HD) in patients with end-stage renal disease. However, its haemodynamic effect on the heart is not negligible; it may cause or exacerbate heart failure and pulmonary hypertension, especially when the flow is excessively high. After the transplantation, a decrease in cardiac output leads to reduced kidney graft perfusion, which can result in the development of cardiorenal syndrome. The guidelines for managing AVF after transplantation are still not well defined, so care and surveillance are based on the experience of transplantation centres. We present a case of a kidney transplant recipient with deterioration of graft function and sepsis. He received a kidney graft in 2005, and since then, he has had a functioning enlarged AVF, which has not been used since the transplantation. At the time of admission, the flow through the fistula exceeded 7000 mL/min. Blood culture results suggested
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.